{'fraction_non_alphanumeric': 0.017452006980802792, 'fraction_numerical': 0.012216404886561954, 'mean_word_length': 4.917525773195877, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Hot topics for debate in prostate cancer: part 1

This report is based on a seminar held during the 8th Annual Meeting of the British Uro‐oncology Group in York last September. Hot topics for debate covered in part 1 of this article are the use of active surveillance for intermediate‐risk prostate cancer and cardiovascular risks in the hormonal management of locally advanced prostate cancer. All participants, most of whom were clinical oncologists, were invited to contribute and respond to set questions using a keypad voting system. Copyright © 2012 John Wiley & Sons